News and Media
;
New directors of OICR Diagnostic Development program set sights on bringing discoveries to the clinic
Dr. Jane Bayani and Dr. Melanie Spears are helping bring new diagnostic tools to patients in their roles as Co-Directors of OICR’s Diagnostic Development program. After more than a decade at OICR driving innovations in cancer diagnostics, Dr. Jane Bayani and Dr. Melanie Spears are leading OICR’s Diagnostic Development program toward even greater clinical impact. […]
Read the story
Feb 02, 2023
OICR researchers join Lancet commission to tackle inequities in precision cancer care
Jan 31, 2023
How research is helping “close the care gap” in cancer
Jan 18, 2023
Pioneer in primary care oncology named to Order of Canada
Jan 17, 2023
The Next Generation: Andy Zeng
Jan 12, 2023
Low-cost molecular test targets more efficient brain cancer diagnosis
Jan 12, 2023
Drug Discovery scientist wants to speed up development of new cancer therapeutics
Recent Videos
Media Contact
Resources
OICR Brand Guidelines
Jul 28, 2021
Download the OICR brand guidelines.
News Releases
Aug 11, 2022
Funding from Ontario Institute for Cancer Research to help move research from experiment to impact
Jun 16, 2022
OICR announces funding for three new window-of-opportunity clinical trials
Dec 02, 2021
Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients
@OICR_News on Twitter
We join @uicc & our partners around the globe in marking #WorldCancerDay. Read how OICR-supported researchers are helping #CloseTheCareGap by building better understanding of inequities in cancer care and finding ways to address them.
https://oicr.on.ca/how-research-is-helping-close-the-care-gap-in-cancer/ #WorldCancerDay2023
Read this week's cancer research news roundup
https://mailchi.mp/oicr/news-roundup-2023-02-03
#cancerresearch #cancernews #genomics #braincancer #ovariancancer #pangenome #breastcancer #immunotherapy #clincaltrials
OICR researchers Drs. @lincolndstein and @mcourtot join @TheLancetOncol Commission to tackle inequities in precision cancer care https://oicr.on.ca/oicr-researchers-join-lancet-commission-to-tackle-inequities-in-precision-cancer-care/
@IcgcArgo @GA4GH #PrecisionMedicine #PrecisionOncology
FACIT is hiring! Check out the job posting for Executive Assistant. Looking for a great career opportunity to help commercialize world-class cancer innovation for patients and drive Ontario economic development? Apply to join our team!
Executive Assistant
FACIT is a strategic vehicle that transforms and accelerates breakthrough oncology discoveries from the Ontario Institut...
bit.ly
It’s Black History Month! Follow along with us this month as we celebrate the legacy and contributions of Black individuals in science and medicine and help amplify Black voices, stories and organizations. #BlackHistoryMonth #BHM2023
Are you an Indigenous undergraduate university or college student looking to gain research or policy experience in the area of cancer?
Apply for the @BioCanRx Indigenous Student Summer Internship Program.
📅 Applications are due February 17.
https://biocanrx.com/training/opportunities/internships/indigenous-students
From @CTVNews: New robotic 3D ultrasound could improve #livercancer treatment
This technology was developed at @WesternU by Dr. Aaron Fenster, co-Director of OICR's Imaging program and is being tested in a clinical trial by Dr. @DerekWCool.
New robotic 3D ultrasound could improve liver cancer treatment: Researchers
A new system that turns ultrasounds into 3D imaging could improve liver cancer treatment, according to a new study...
london.ctvnews.ca
Please join us this Friday for the Mark Ernsting Drug Discovery Memorial Lecture as we honour Dr. Ernsting's legacy and hear from Dr. John Valliant on “225Ac-Based Targeted Alpha Therapies (TATs): Research to Clinical Trials”.
Registration: https://forms.office.com/pages/responsepage.aspx?id=-En5neumnUGcqh-Mg9tnTwhTsL1OqLdOkbIeLIPT6YpUMFpDMlFSSFdGQzZDWVBEOVozMU9IUjFXTi4u
Last chance! The deadline to submit pitch abstracts for @FACITca's Falcons' Fortunes is tomorrow at 5 p.m. 🦅
Elevate your #MadeInOntario cancer innovation at FACIT's 10th Falcons' Fortunes pitch competition for $100,000, being held in person in Toronto Mar 30/23. Pitch abstracts are due by Jan 27. For more details https://facit.ca/funds/falcons-fortunes
Please join us this Friday for the Mark Ernsting Drug Discovery Memorial Lecture as we honour Dr. Ernsting's legacy and hear from Dr. John Valliant on “225Ac-Based Targeted Alpha Therapies (TATs): Research to Clinical Trials”.
Registration: https://forms.office.com/pages/responsepage.aspx?id=-En5neumnUGcqh-Mg9tnTwhTsL1OqLdOkbIeLIPT6YpUMFpDMlFSSFdGQzZDWVBEOVozMU9IUjFXTi4u
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.